Food and Drug Administration Rejects Moderna's Flu Vaccine

The Food and Drug Administration refused to review the application for a messenger RNA flu vaccine from Moderna due to objections regarding clinical trial design.Robert F. Kennedy Jr. and Vinay Prasad emphasized that the study failed to compare the shot against the highest standard of care for senior citizens.While CEO Stéphane Bancel and other critics argued the decision lacks scientific merit, the move coincides with the USA government cutting $500 million in funding for messenger RNA technology development.